- Home
- Services
- usa new york
- vaccine development
Show results for
Refine by
Vaccine Development Services In Usa New York
6 services found
Manufactured by:Alfa Chemistry based inNY, NEW YORK (USA)
Phospholipids as Nucleic Acid Delivery Excipients: Phospholipids are unique and versatile molecules that are a key component of all cell membranes. A phospholipid consists of two basic parts: the hydrophilic head and the hydrophobic tail. The hydrophilic head consists of a glycerol molecule bound to a phosphate group. These groups are polar and are attracted to water. ...
Manufactured by:CD Biosciences - htDNA-chip® based inShirley, NEW YORK (USA)
The nucleic acid vaccines development process is mainly divided into the following steps: isolation and screening of pathogenic genes, sequencing of pathogenic genes, targeted cloning of antigen genes, the introduction of recombinant genes into recipient cells, screening and identification of recombinant genes, and large-scale antigen gene synthesis. As we all ...
Manufactured by:Creative Biolabs based inShirley, NEW YORK (USA)
Advances in recombinant DNA technology, genomics and immunology have greatly affected the vaccine development ...
Manufactured by:CDBioSciences - VLPlant based inShirley, NEW YORK (USA)
CD BioSciences has a sophisticated VLPlant platform and extensive experience in modifying VLPs by chemical conjugation to produce chimeric virus-like particles (cVLPs) for your development of vaccines, nanomaterials and ...
Manufactured by:CDBioSciences - VLPlant based inShirley, NEW YORK (USA)
As a leading global provider of custom services, CD BioSciences has advanced facilities and experienced scientists dedicated to cVLPs development services to help our customers develop vaccines, nanomaterials and diagnostic ...
Manufactured by:CDBioSciences - VLPlant based inShirley, NEW YORK (USA)
Virus-like particles (VLPs) are nanoscale structures composed of assembled viral proteins that lack viral genetic material and are therefore not infectious. CD BioSciencesoffers VLPlantTM, a plant-based recombinant expression system for constructing VLPs, which offers many advantages over traditional mammalian, yeast, insect, and bacterial expression ...